Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest
Rhea-AI Summary
Tevogen Bio Holdings (NASDAQ: TVGN) has announced plans to provide detailed guidance on the Direct Registration System (DRS) process in response to increased shareholder inquiries. The announcement follows growing interest from shareholders seeking information on transferring their shares to DRS accounts. The company revealed that several of its major shareholders, both internal and external, have already opted for DRS as their preferred method of share ownership, demonstrating confidence in this direct ownership approach.
The company will release step-by-step instructions next week to assist shareholders in registering their shares directly with Continental Stock Transfer & Trust, Tevogen's transfer agent.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, TVGNW gained 0.21%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
WARREN, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that, following the Company’s recent press release highlighting the Direct Registration System (DRS) as a secure method of share ownership, it has received a number of inquiries from shareholders seeking additional information on how to transfer their shares to a DRS account.
In response, Tevogen will provide step-by-step guidance early next week to help interested shareholders register their shares directly with the Company’s transfer agent, Continental Stock Transfer & Trust.
The Company also notes that several of its largest shareholders, both internal and external, have elected to hold their shares via DRS, underscoring their confidence in this method of direct ownership.
Contacts
Tevogen Bio Communications
T: 1 877 TEVOGEN, Ext 701
Communications@Tevogen.com